Discover Stem Cell Therapy Options in the United States
This specialized protocol is designed to slow the progression of Chronic Kidney Disease (CKD), reduce inflammation, and promote renal tissue regeneration. The treatment combines Mesenchymal Stem Cells (MSCs) derived from either Adipose tissue or Umbilical Cord Cells, depending on patient suitability. These cells have potent anti-inflammatory, immunomodulatory, and regenerative effects that help restore kidney microcirculation, reduce fibrosis, and support nephron repair.
To enhance therapeutic results, Exosomes are added to the infusion. These nano-sized vesicles carry essential growth factors and cytokines that promote cellular communication, protect renal cells from oxidative stress, and accelerate tissue recovery. The MSC–Exosome combination improves kidney filtration function and supports systemic healing.
Additionally, the peptide combination of BPC-157 and TB-500 is included to optimize vascular health, reduce systemic inflammation, and enhance the regenerative environment within the kidneys. BPC-157 promotes endothelial repair and reduces renal inflammation, while TB-500 supports improved blood flow and tissue oxygenation.
The treatment is administered through Intravenous infusion, with an optional intra-arterial or targeted injection for enhanced delivery to the renal region (if appropriate).
Goal: Decrease renal inflammation, improve kidney function, enhance energy, and delay disease progression through comprehensive cellular regeneration.
Share this listing